Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man

Psychopharmacology

Volumn 182, Issue 3, 2005, Pages 375-383

  Aalto, Sargo ^a,b   Ihalainen, Jouni ^c   Hirvonen, Jussi ^a   Kajander, Jaana ^a   Scheinin, Harry ^a   Tanila, Heikki ^c,d   Någren, Kjell ^a   Vilkman, Harry ^a   Gustafsson, Lars L ^e   Syvälahti, Erkka ^a   Hietala, Jarmo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

11C FLB 457; Dopamine; Glutamate; Positron emission tomography; Psychosis; Schizophrenia

Indexed keywords

CARBON 11; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMIC ACID; ISOREMOXIPRIDE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN LEVEL; CINGULATE GYRUS; COMPUTER ANALYSIS; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MICRODIALYSIS; MOLECULAR INTERACTION; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT; RECEPTOR DENSITY; SCHIZOPHRENIA;

ADULT; ANIMALS; CARBON RADIOISOTOPES; CEREBRAL CORTEX; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HUMANS; KETAMINE; MALE; MICRODIALYSIS; POSITRON-EMISSION TOMOGRAPHY; PSYCHOSES, SUBSTANCE-INDUCED; PYRROLIDINES; RATS; SALICYLAMIDES;

EID: 26844447871     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0092-6     Document Type: Article

References (65)

1. Aalto S, Hirvonen J, Kajander J, Scheinin H, Någren K, Vilkman H, Gustafsson L, Syvälahti E, Hietala J (2002) Ketamine does not decrease striatal dopamine D2 receptor binding in man. Psychopharmacology (Berl) 164:401-406
2. Aalto S, Bruck A, Laine M, Nagren K, Rinne JO (2005) Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci 25:2471-2477
3. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
4. Adams BW, Bradberry CW, Moghaddam B (2002) NMDA Antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Synapse 43:12-18
5. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD (1997) Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet 349:1730-1734
6. Breier A, Malhotra A, Pinals D, Weisenfeld N, Pickar D (1997) Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatr 154:805-811
7. Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D (1998) Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29:142-147
8. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276
9. Carlsson A, Waters N, Carlsson ML (1999) Neurotransmitter interactions in schizophrenia - therapeutic implications. Biol Psychiatry 46:1388-1395
10. Carr DB, Sesack SR (2000) Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 20:3864-3873
11. Chou YH, Halldin C, Farde L (2000) Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET Study. Synapse 38:138-143
12. Cooper BG, Manka TF, Mizumori SJ (2001) Finding your way in the dark: the retrosplenial cortex contributes to spatial memory and navigation without visual cues. Behav Neurosci 115:1012-1028
13. Dagher A, Gunn R, Lockwood G, Cunningham VJ, Grasby PM, Brooks DJ (1998) Measuring neurotransmitter release with PET: methodological issues. In: Carlson R, Daube-Withespoon ME, Herscovitch P (eds) Quantitative functional brain imaging with positron emission tomography. Academic, San Diego, pp 449-454
14. Descarries L, Lemay B, Doucet G, Berger B (1987) Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21:807-824
15. Deutch, AY, Roth RH (1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res 85:367-402
16. Domino EF, Domino SE, Smith RE, Domino LE, Goulet JR, Domino KE, Zsigmond EK (1984) Ketamine kinetics in unmedicated and diazepam-premedicated subjects. Clin Pharmacol Ther 36:563-645
17. Farber NB, Price MT, Labruyere J, Nemnich J, St Peter H, Wozniak DF, Olney JW (1993) Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol Psychiatry 34:119-121
18. Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, Halldin C (1997) A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychophannacology (Berl) 133:396-404
19. Friston KJ, Holmes AP, Worsley KJ, Poline J-B, Frith CD, Frackowiak RS (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189-210
20. Fujita M, Verhoeff NP, Varrone A, Zoghbi SS, Baldwin RM, Jatlow PA, Anderson GM, Seibyl JP, Innis RB (2000) Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans. Eur J Pharmacol 387:179-188
21. Gaspar P, Berger B, Febvret A, Vigny A, Henry JP (1989) Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 279:249-271
22. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997) Parametric imaging of ligand-receptor binding using a simplified reference region model. Neuroimage 6:279-287
23. Hagelberg N, Aalto S, Kajander J, Oikonen V, Hinkka S, Någren K, Hietala J, Scheinin H (2004) Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects. Pain 109:86-93
24. Hall H, Farde L, Halldin C, Hurd Y-L, Pauli S, Sedvall G (1996) Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse 23:15-23
25. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel BV, Lohr J, Wu J, Haier RJ, Bunney WE Jr (1997) Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatr 154:682-684
26. Ihalainen JA, Tanila H (2002) In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex. Eur J Neurosci 15:1789-1794
27. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatr 148:1301-1308
28. Kapur S, Seeman P (2001) Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol Psychiatry 49:954-955
29. Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M (2000) Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48:627-640
30. Kegeles LS, Martinez D, Kochan LD, Hwang D-R, Huang Y, Mawlawi O, Suckow RF, Van Heertum RL, Laruelle M (2002) NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans. Synapse 43:19-29
31. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
32. Krystal JH, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D, Cassello K, Bowers MB Jr, Vegso S, Heninger GR, Charney DS (1999) Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology (Berl) 145:193-204
33. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995) Katemine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 6:869-872
34. Lammerstma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158
35. Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451
36. Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A (2001) Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol 432:119-136
37. Li Q, Clark S, Lewis DV, Wilson WA (2002) NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci 22:3070-3080
38. Lindefors N, Barati S, O'Connor WT (1997) Differential effects of single and repeated ketamine administration on dopamine, serotinin and GABA transmission in rat medial prefrontal cortex. Brain Res 759:205-212
39. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003) Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697-706
40. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenomimetic drug: serenyl. Arch Neurol Psychiatry 71:363-369
41. Moghaddam B (2002) Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 51:775-787
42. Moore H, West AR, Grace AA (1999) The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 46:40-55
43. Nishimura M, Sato K (1999) Ketamine stereo selectively inhibits rat dopamine transporter. Neurosci Lett 274:131-134
44. Okauchi T, Suhara T, Maeda J, Kawabe K, Obayashi S, Suzuki K (2001) Effect of endogenous dopamine on endogenous dopamine on extrastriated[(11)C]FLB 457 binding measured by PET. Synapse 41:87-95
45. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
46. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362
47. Olsson H, Halldin C, Swahn CG, Farde L (1999) Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab 19:1164-1173
48. Olsson H, Halldin C, Farde L (2004) Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage 22:794-803
49. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
50. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire PK (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281-288
51. Sesack SR, Carr DB, Omelchenko N, Pinto A (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann N Y Acad Sci 1003:36-52
52. Sharp FR, Jasper P, Hall J, Noble L, Sagar SM (1991) MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol 30:801-809
53. Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD (2003) Neurochemical and behavioral differences between D-methamphetamine and D-amphetamine in rats. Psychopharmacology 165:359-369
54. Shoblock JR, Maisonneuve IM, Glick SD (2004) Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex. Neurochem Res 29:1437-1442
55. Slifstein M, Lamelle M (2001) Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 28:595-608
56. Slifstein M, Narendran R, Hwang DR, Sudo Y, Talbot PS, Huang Y, Laruelle M (2004) Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: single bolus and bolus plus constant infusion studies. Synapse 54:46-63
57. Smith GS, Schloesser R, Brodie JD, Dewey SL, Logan J, Vitkun SA, Simkowitz P, Hurley A, Cooper T, Volkow ND, Cancro R (1998) Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects. Neuropsychopharmacology 18:18-25
58. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T, Halldin C, Farde L (2001) Reproducibility of [11C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 22:1215-1221
59. Suhara T, Okubo Y, Yasuno F, Sudo Y, Inoue M, Ichimiya T, Nakashima Y, Nakayama K, Tanada S, Suzuki K, Halldin C, Farde L (2002) Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry 59:25-30
60. Svensson JO, Gustafsson LL (1996) Determination of ketamine and norketamine enantiomers in plasma by solid phase extraction and high performance liquid chromatography. J Chromatogr 678:373-376
61. Takahata R, Moghaddam B (2003) Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J Neurochem 75:1775-1778
62. Vann SD, Aggleton JP (2002) Extensive cytotoxic lesions of the rat retrosplenial cortex reveal consistent deficits on tasks that tax allocentric spatial memory. Behav Neurosci 116:85-94
63. Verma A, Moghaddam B (1996) The role of excitatory amino acids in prefrontal cortex function as assessed by spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16:373-379
64. Vilkman H, Kajander J, Någren K, Oikonen V, Syvälahti E, Hietala J (2000) Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457 - a test-retest analysis. Eur J Nucl Med 27:1666-1673
65. Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL (2000) Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J Psychiatr Res 34:35-43